Abstract
High levels of plasminogen activator inhibitor-1 (PAI-1), which is produced by stromal, endothelial, and cancer cells and has multiple complex effects on cancers, correlate with poor cancer prognosis. To more definitively study the role of endogenously produced PAI-1 in human pancreatic adenocarcinoma (PAC) PANC-1 cell line biology, we used anti-PAI-1 shRNA to create stable PAI-1 deficient cells (PD-PANC-1s). PD-PANC-1s exhibited a heterogeneous morphology. While the majority of cells exhibited a cuboidal shape similar to the parental PANC-1 or the vector-infected control cells, numerous large cells with long filopodia and a neuronal-like appearance were observed. Although both Vector-control cells and PD-PANC-1s expressed mRNAs that are characteristic of mesenchymal, neural, and epithelial phenotypes, epithelial marker RNAs were up-regulated (e.g., E-cadherin, 32-fold) whereas mesenchymal marker RNAs were down-regulated (e.g., Thy1, ninefold) in PD-PANC-1s, suggesting mesenchymal-to-epithelial transition. Neural markers exhibited both up- and down-regulation. Immunocytochemistry indicated that epithelial-like PD-PANC-1s expressed E-cadherin and β-catenin in significantly more cells, while neural-like cells exhibited robust exp...Continue Reading
References
Jul 1, 1991·Seminars in Thrombosis and Hemostasis·F JänickeH Graeff
Oct 3, 1996·Nature·S Stefansson, D A Lawrence
May 15, 1997·The EMBO Journal·A NykjaerF Blasi
Aug 13, 1998·Nature Medicine·K BajouJ M Foidart
May 22, 2001·Molecular Biology of the Cell·R P CzekayM G Farquhar
Oct 28, 2003·The American Journal of Pathology·Birgitte Vrou OffersenPeter A Andreasen
Feb 26, 2004·Thrombosis and Haemostasis·Nadia HarbeckManfred Schmitt
Aug 3, 2004·Oncogene·Khalid BajouAgnès Noel
Nov 27, 2004·Science·Marvin C GershengornBruce M Raaka
Jan 28, 2005·Oncogene·Catherine Fen LiBenjamin A Alman
Feb 22, 2005·Neoplasia : an International Journal for Oncology Research·Catherine MaillardAgnès Noel
Apr 21, 2005·Thrombosis and Haemostasis·Keld DanøJohn Rømer
May 3, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ulrik LademannNils Brünner
Jan 6, 2006·International Journal of Cancer. Journal International Du Cancer·Pia LindbergBoye Schnack Nielsen
Jul 25, 2006·Nature Cell Biology·Roderik M KortleverRené Bernards
Mar 8, 2007·Acta Biochimica Et Biophysica Sinica·Huiling YangWeixin Hu
Mar 28, 2008·Journal of Cellular Physiology·Naamit DeshetYoram Oron
May 23, 2008·Immunology Letters·Bernd R Binder, Judit Mihaly
Jun 10, 2008·Developmental Cell·Jing Yang, Robert A Weinberg
Jul 11, 2008·The Journal of Biological Chemistry·Roderik M KortleverRené Bernards
Jan 21, 2009·Cancer Metastasis Reviews·Otto SchmalhoferThomas Brabletz
Feb 10, 2009·Current Cancer Drug Targets·Salvatore UlisseMassimino D'Armiento
Jun 3, 2009·The Journal of Biological Chemistry·Benjamin S PedrojaAudrey M Bernstein
Jun 10, 2009·Nature Reviews. Gastroenterology & Hepatology·Han H Wong, Nicholas R Lemoine
Apr 17, 2010·Genome Research·Joris van ArensbergenJorge Ferrer
May 4, 2011·Vascular Cell·Rashna D BalsaraVictoria A Ploplis
Nov 22, 2011·Cancer Science·Nobuaki NishiokaJohn D Roberts
Citations
Feb 8, 2013·Diabetes/metabolism Research and Reviews·P MatafomeR Seiça
Oct 14, 2018·Cancers·Norbaini Binti Abdol RazakPat Metharom
Dec 13, 2018·Chinese Medical Journal·Wen-Jing LiuYu-Pei Zhao
Nov 27, 2019·Cell Death & Disease·Elodie RogerLaurent Bartholin
Mar 20, 2019·Cancer Chemotherapy and Pharmacology·Davide MelisiJosep Tabernero
May 25, 2016·Cancer Research·Sandeep K BotlaJörg D Hoheisel
Jan 14, 2021·Journal for Immunotherapy of Cancer·Tamara A SussmanAlok A Khorana
Jan 27, 2021·Blood Advances·Yohei HisadaCihan Ay
Nov 5, 2019·Biochimica Et Biophysica Acta. Molecular Cell Research·Xupin JiangYuesheng Huang